196 related articles for article (PubMed ID: 1321334)
1. Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells.
Kavanaugh WM; Klippel A; Escobedo JA; Williams LT
Mol Cell Biol; 1992 Aug; 12(8):3415-24. PubMed ID: 1321334
[TBL] [Abstract][Full Text] [Related]
2. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors.
Hu P; Margolis B; Skolnik EY; Lammers R; Ullrich A; Schlessinger J
Mol Cell Biol; 1992 Mar; 12(3):981-90. PubMed ID: 1372091
[TBL] [Abstract][Full Text] [Related]
3. SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.
McGlade CJ; Ellis C; Reedijk M; Anderson D; Mbamalu G; Reith AD; Panayotou G; End P; Bernstein A; Kazlauskas A
Mol Cell Biol; 1992 Mar; 12(3):991-7. PubMed ID: 1372092
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.
Klippel A; Escobedo JA; Fantl WJ; Williams LT
Mol Cell Biol; 1992 Apr; 12(4):1451-9. PubMed ID: 1312663
[TBL] [Abstract][Full Text] [Related]
5. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
Nishimura R; Li W; Kashishian A; Mondino A; Zhou M; Cooper J; Schlessinger J
Mol Cell Biol; 1993 Nov; 13(11):6889-96. PubMed ID: 7692233
[TBL] [Abstract][Full Text] [Related]
6. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions.
Heidaran MA; Beeler JF; Yu JC; Ishibashi T; LaRochelle WJ; Pierce JH; Aaronson SA
J Biol Chem; 1993 May; 268(13):9287-95. PubMed ID: 8387491
[TBL] [Abstract][Full Text] [Related]
7. In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase.
Cooper JA; Kashishian A
Mol Cell Biol; 1993 Mar; 13(3):1737-45. PubMed ID: 8382774
[TBL] [Abstract][Full Text] [Related]
8. The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes.
Roche S; Dhand R; Waterfield MD; Courtneidge SA
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):703-11. PubMed ID: 7519847
[TBL] [Abstract][Full Text] [Related]
9. A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine.
Escobedo JA; Kaplan DR; Kavanaugh WM; Turck CW; Williams LT
Mol Cell Biol; 1991 Feb; 11(2):1125-32. PubMed ID: 1703628
[TBL] [Abstract][Full Text] [Related]
10. Common and distinct elements in insulin and PDGF signaling.
Myers MG; Cheatham B; Fisher TL; Jachna BR; Kahn CR; Backer JM; White MF
Ann N Y Acad Sci; 1995 Sep; 766():369-87. PubMed ID: 7486683
[TBL] [Abstract][Full Text] [Related]
11. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor.
Escobedo JA; Navankasattusas S; Kavanaugh WM; Milfay D; Fried VA; Williams LT
Cell; 1991 Apr; 65(1):75-82. PubMed ID: 1849460
[TBL] [Abstract][Full Text] [Related]
12. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85.
Yamamoto K; Altschuler D; Wood E; Horlick K; Jacobs S; Lapetina EG
J Biol Chem; 1992 Jun; 267(16):11337-43. PubMed ID: 1317864
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity.
Klinghoffer RA; Duckworth B; Valius M; Cantley L; Kazlauskas A
Mol Cell Biol; 1996 Oct; 16(10):5905-14. PubMed ID: 8816504
[TBL] [Abstract][Full Text] [Related]
14. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.
Myers MG; Backer JM; Sun XJ; Shoelson S; Hu P; Schlessinger J; Yoakim M; Schaffhausen B; White MF
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10350-4. PubMed ID: 1332046
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes.
Panayotou G; Bax B; Gout I; Federwisch M; Wroblowski B; Dhand R; Fry MJ; Blundell TL; Wollmer A; Waterfield MD
EMBO J; 1992 Dec; 11(12):4261-72. PubMed ID: 1330535
[TBL] [Abstract][Full Text] [Related]
16. The smaller isoforms of ankyrin 3 bind to the p85 subunit of phosphatidylinositol 3'-kinase and enhance platelet-derived growth factor receptor down-regulation.
Ignatiuk A; Quickfall JP; Hawrysh AD; Chamberlain MD; Anderson DH
J Biol Chem; 2006 Mar; 281(9):5956-64. PubMed ID: 16377635
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 subunit to tyrosine-phosphorylated PDGF receptor.
McGuire TF; Corey SJ; Sebti SM
J Biol Chem; 1993 Oct; 268(30):22227-30. PubMed ID: 7693661
[TBL] [Abstract][Full Text] [Related]
18. Insulin-induced activation of phosphatidylinositol (PI) 3-kinase. Insulin-induced phosphorylation of insulin receptors and insulin receptor substrate-1 displaces phosphorylated platelet-derived growth factor receptors from binding sites on PI 3-kinase.
Levy-Toledano R; Blaettler DH; LaRochelle WJ; Taylor SI
J Biol Chem; 1995 Dec; 270(50):30018-22. PubMed ID: 8530404
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of the Src homology 2 domains of phospholipase C-gamma1 (PLC-gamma1) in platelet-derived growth factor-induced activation of PLC-gamma1 in intact cells.
Poulin B; Sekiya F; Rhee SG
J Biol Chem; 2000 Mar; 275(9):6411-6. PubMed ID: 10692443
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine 508 of the 85-kilodalton subunit of phosphatidylinositol 3-kinase is phosphorylated by the platelet-derived growth factor receptor.
Kavanaugh WM; Turck CW; Klippel A; Williams LT
Biochemistry; 1994 Sep; 33(36):11046-50. PubMed ID: 8086421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
